Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 482


Consequences of alcohol and marijuana use among college students: Prevalence rates and attributions to substance-specific versus simultaneous use.

Jackson KM, Sokolovsky AW, Gunn RL, White HR.

Psychol Addict Behav. 2020 Jan 16. doi: 10.1037/adb0000545. [Epub ahead of print]


Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.

Onwordi EC, Halff EF, Whitehurst T, Mansur A, Cotel MC, Wells L, Creeney H, Bonsall D, Rogdaki M, Shatalina E, Reis Marques T, Rabiner EA, Gunn RN, Natesan S, Vernon AC, Howes OD.

Nat Commun. 2020 Jan 14;11(1):246. doi: 10.1038/s41467-019-14122-0.


Preclinical evaluation of [18F]FB-A20FMDV2 as a selective marker for measuring αVβ6 integrin occupancy using positron emission tomography in rodent lung.

Onega M, Parker CA, Coello C, Rizzo G, Keat N, Ramada-Magalhaes J, Moz S, Tang SP, Plisson C, Wells L, Ashworth S, Slack RJ, Vitulli G, Wilson FJ, Gunn R, Lukey PT, Passchier J.

Eur J Nucl Med Mol Imaging. 2020 Jan 3. doi: 10.1007/s00259-019-04653-5. [Epub ahead of print]


Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study).

Lukey PT, Coello C, Gunn R, Parker C, Wilson FJ, Saleem A, Garman N, Costa M, Kendrick S, Onega M, Kang'ombe AR, Listanco A, Davies J, Ramada-Magalhaes J, Moz S, Fahy WA, Maher TM, Jenkins G, Passchier J, Marshall RP.

Eur J Nucl Med Mol Imaging. 2019 Dec 9. doi: 10.1007/s00259-019-04586-z. [Epub ahead of print]


Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge.

Erritzoe D, Ashok AH, Searle GE, Colasanti A, Turton S, Lewis Y, Huiban M, Moz S, Passchier J, Saleem A, Beaver J, Lingford-Hughes A, Nutt DJ, Howes OD, Gunn RN, Knudsen GM, Rabiner EA.

Neuropsychopharmacology. 2019 Nov 12. doi: 10.1038/s41386-019-0567-5. [Epub ahead of print]


A longitudinal examination of daily patterns of cannabis and alcohol co-use among medicinal and recreational veteran cannabis users.

Gunn R, Jackson K, Borsari B, Metrik J.

Drug Alcohol Depend. 2019 Dec 1;205:107661. doi: 10.1016/j.drugalcdep.2019.107661. Epub 2019 Oct 23.


Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET study.

Wilson H, Dervenoulas G, Pagano G, Tyacke RJ, Polychronis S, Myers J, Gunn RN, Rabiner EA, Nutt D, Politis M.

Brain. 2019 Oct 1;142(10):3116-3128. doi: 10.1093/brain/awz260.


In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury.

Gorgoraptis N, Li LM, Whittington A, Zimmerman KA, Maclean LM, McLeod C, Ross E, Heslegrave A, Zetterberg H, Passchier J, Matthews PM, Gunn RN, McMillan TM, Sharp DJ.

Sci Transl Med. 2019 Sep 4;11(508). pii: eaaw1993. doi: 10.1126/scitranslmed.aaw1993.


Longitudinal (18F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation.

Convery RS, Jiao J, Clarke MTM, Moore KM, Koriath CAM, Woollacott IOC, Weston PSJ, Gunn R, Rabiner I, Cash DM, Rossor MN, Warren JD, Fox NC, Ourselin S, Bocchetta M, Rohrer JD.

J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):106-108. doi: 10.1136/jnnp-2019-320904. Epub 2019 Aug 22. No abstract available.


Enhancing the Control of Syphilis Among Men Who Have Sex With Men by Focusing on Acute Infectious Primary Syphilis and Core Transmission Groups.

Gunn RA, Klausner JD.

Sex Transm Dis. 2019 Oct;46(10):629-636. doi: 10.1097/OLQ.0000000000001039.


Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression.

Jolly AE, Raymont V, Cole JH, Whittington A, Scott G, De Simoni S, Searle G, Gunn RN, Sharp DJ.

Neuroimage Clin. 2019;24:101950. doi: 10.1016/j.nicl.2019.101950. Epub 2019 Jul 22.


Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J.

Mansur A, Rabiner EA, Comley RA, Lewis Y, Middleton LT, Huiban M, Passchier J, Tsukada H, Gunn RN; MIND-MAPS Consortium.

J Nucl Med. 2020 Jan;61(1):96-103. doi: 10.2967/jnumed.119.228080. Epub 2019 Jul 19.


Translating Research into Agile Development (TRIAD): Development of Electronic Health Record Tools for Primary Care Settings.

Clark KD, Woodson TT, Holden RJ, Gunn R, Cohen DJ.

Methods Inf Med. 2019 Jun;58(1):1-8. doi: 10.1055/s-0039-1692464. Epub 2019 Jul 5.


Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M.

Lancet Neurol. 2019 Aug;18(8):748-759. doi: 10.1016/S1474-4422(19)30140-1. Epub 2019 Jun 19.


Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease.

Pagano G, Niccolini F, Wilson H, Yousaf T, Khan NL, Martino D, Plisson C, Gunn RN, Rabiner EA, Piccini P, Foltynie T, Politis M.

Mov Disord. 2019 Oct;34(10):1505-1515. doi: 10.1002/mds.27733. Epub 2019 Jun 3.


Imaging of Chemotherapy-Induced Acute Cardiotoxicity with 18F-Labeled Lipophilic Cations.

McCluskey SP, Haslop A, Coello C, Gunn RN, Tate EW, Southworth R, Plisson C, Long NJ, Wells LA.

J Nucl Med. 2019 Dec;60(12):1750-1756. doi: 10.2967/jnumed.119.226787. Epub 2019 May 30.


Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.

Martín-Bastida A, Lao-Kaim NP, Roussakis AA, Searle GE, Xing Y, Gunn RN, Schwarz ST, Barker RA, Auer DP, Piccini P.

Brain. 2019 Jul 1;142(7):2023-2036. doi: 10.1093/brain/awz120.


Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.

Koychev I, Lawson J, Chessell T, Mackay C, Gunn R, Sahakian B, Rowe JB, Thomas AJ, Rochester L, Chan D, Tom B, Malhotra P, Ballard C, Chessell I, Ritchie CW, Raymont V, Leroi I, Lengyel I, Murray M, Thomas DL, Gallacher J, Lovestone S.

BMJ Open. 2019 Mar 23;9(3):e024498. doi: 10.1136/bmjopen-2018-024498.


A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices.

Carney PA, Hatch B, Stock I, Dickinson C, Davis M, Larsen R, Valenzuela S, Marino M, Darden PM, Gunn R, Ferrara L, Fagnan LJ.

Implement Sci. 2019 Mar 14;14(1):30. doi: 10.1186/s13012-019-0871-9.


Aligning systems science and community-based participatory research: A case example of the Community Health Advocacy and Research Alliance (CHARA).

Davis MM, Lindberg P, Cross S, Lowe S, Gunn R, Dillon K.

J Clin Transl Sci. 2018 Oct;2(5):280-288. doi: 10.1017/cts.2018.334.


The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease.

Wilson H, Pagano G, Niccolini F, Muhlert N, Mehta MA, Searle G, Gunn RN, Rabiner EA, Foltynie T, Politis M.

Parkinsonism Relat Disord. 2019 Feb 22. pii: S1353-8020(19)30073-2. doi: 10.1016/j.parkreldis.2019.02.027. [Epub ahead of print]


Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R.

Mol Imaging Biol. 2019 Oct;21(5):935-944. doi: 10.1007/s11307-019-01323-8.


The effects of fatigue on the running profile of elite team sport athletes. A systematic review and meta-analysis.

Garrett JM, Gunn R, Eston RG, Jakeman J, Burgess DJ, Norton K.

J Sports Med Phys Fitness. 2019 Aug;59(8):1328-1338. doi: 10.23736/S0022-4707.19.09356-3. Epub 2019 Feb 12.


Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region.

Plavén-Sigray P, Schain M, Zanderigo F; Karolinska [(11)C]PBR28 study group, Rabiner EA, Gunn RN, Ogden RT, Cervenka S.

Neuroimage. 2019 Mar;188:102-110. doi: 10.1016/j.neuroimage.2018.11.020. Epub 2018 Nov 27.


Clinical Workflows and the Associated Tasks and Behaviors to Support Delivery of Integrated Behavioral Health and Primary Care.

Davis MM, Gunn R, Cifuentes M, Khatri P, Hall J, Gilchrist E, Peek CJ, Klowden M, Lazarus JA, Miller BF, Cohen DJ.

J Ambul Care Manage. 2019 Jan/Mar;42(1):51-65. doi: 10.1097/JAC.0000000000000257.


Designing health information technology tools for behavioral health clinicians integrated within a primary care team.

Woodson TT, Gunn R, Clark KD, Balasubramanian BA, Jetelina KK, Muller B, Miller BF, Burdick TE, Cohen DJ.

J Innov Health Inform. 2018 Oct 31;25(3):158-168. doi: 10.14236/jhi.v25i3.998.


Marijuana use is associated with alcohol use and consequences across the first 2 years of college.

Gunn RL, Norris AL, Sokolovsky A, Micalizzi L, Merrill JE, Barnett NP.

Psychol Addict Behav. 2018 Dec;32(8):885-894. doi: 10.1037/adb0000416. Epub 2018 Oct 25.


PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.

Niccolini F, Mencacci NE, Yousaf T, Rabiner EA, Salpietro V, Pagano G, Balint B, Efthymiou S, Houlden H, Gunn RN, Wood N, Bhatia KP, Politis M.

Mov Disord. 2018 Dec;33(12):1961-1965. doi: 10.1002/mds.27523. Epub 2018 Oct 21.


Predictors of Effective Working Memory Training in Individuals with Alcohol Use Disorders.

Gunn RL, Gerst KR, Wiemers EA, Redick TS, Finn PR.

Alcohol Clin Exp Res. 2018 Dec;42(12):2432-2441. doi: 10.1111/acer.13892. Epub 2018 Oct 25.


Evaluation of an Electronic Health Record (EHR) Tool for Integrated Behavioral Health in Primary Care.

Jetelina KK, Woodson TT, Gunn R, Muller B, Clark KD, DeVoe JE, Balasubramanian BA, Cohen DJ.

J Am Board Fam Med. 2018 Sep-Oct;31(5):712-723. doi: 10.3122/jabfm.2018.05.180041.


Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging.

Whittington A, Gunn RN; Alzheimer’s Disease Neuroimaging Initiative.

J Nucl Med. 2019 Apr;60(4):536-540. doi: 10.2967/jnumed.118.210518. Epub 2018 Sep 6.


Disease-related patterns of in vivo pathology in Corticobasal syndrome.

Niccolini F, Wilson H, Hirschbichler S, Yousaf T, Pagano G, Whittington A, Caminiti SP, Erro R, Holton JL, Jaunmuktane Z, Esposito M, Martino D, Abdul A, Passchier J, Rabiner EA, Gunn RN, Bhatia KP, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2413-2425. doi: 10.1007/s00259-018-4104-2. Epub 2018 Aug 8.


First evaluation of PET-based human biodistribution and radiation dosimetry of 11C-BU99008, a tracer for imaging the imidazoline2 binding site.

Venkataraman AV, Keat N, Myers JF, Turton S, Mick I, Gunn RN, Rabiner EA, Passchier J, Parker CA, Tyacke RJ, Nutt DJ.

EJNMMI Res. 2018 Jul 30;8(1):71. doi: 10.1186/s13550-018-0429-x.


Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.

Turton S, Myers JF, Mick I, Colasanti A, Venkataraman A, Durant C, Waldman A, Brailsford A, Parkin MC, Dawe G, Rabiner EA, Gunn RN, Lightman SL, Nutt DJ, Lingford-Hughes A.

Mol Psychiatry. 2018 Jun 25. doi: 10.1038/s41380-018-0107-4. [Epub ahead of print]


Locomotor activity, emotionality, sensori-motor gating, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.

O'Leary TP, Hussin AT, Gunn RK, Brown RE.

Brain Res Bull. 2018 Jun;140:347-354. doi: 10.1016/j.brainresbull.2018.05.021. Epub 2018 Jun 2.


Brain lesion segmentation through image synthesis and outlier detection.

Bowles C, Qin C, Guerrero R, Gunn R, Hammers A, Dickie DA, Valdés Hernández M, Wardlaw J, Rueckert D.

Neuroimage Clin. 2017 Sep 8;16:643-658. doi: 10.1016/j.nicl.2017.09.003. eCollection 2017.


Negative urgency partially accounts for the relationship between major depressive disorder and marijuana problems.

Gunn RL, Jackson KM, Borsari B, Metrik J.

Borderline Personal Disord Emot Dysregul. 2018 May 16;5:10. doi: 10.1186/s40479-018-0087-7. eCollection 2018.


Building a database for brain 18 kDa translocator protein imaged using [11C]PBR28 in healthy subjects.

Paul S, Gallagher E, Liow JS, Mabins S, Henry K, Zoghbi SS, Gunn RN, Kreisl WC, Richards EM, Zanotti-Fregonara P, Morse CL, Hong J, Kowalski A, Pike VW, Innis RB, Fujita M.

J Cereb Blood Flow Metab. 2019 Jun;39(6):1138-1147. doi: 10.1177/0271678X18771250. Epub 2018 May 11.


Daily Patterns of Marijuana and Alcohol Co-Use Among Individuals with Alcohol and Cannabis Use Disorders.

Metrik J, Gunn RL, Jackson KM, Sokolovsky AW, Borsari B.

Alcohol Clin Exp Res. 2018 Jun;42(6):1096-1104. doi: 10.1111/acer.13639. Epub 2018 May 8.


Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.

Mc Ardle R, Morris R, Hickey A, Del Din S, Koychev I, Gunn RN, Lawson J, Zamboni G, Ridha B, Sahakian BJ, Rowe JB, Thomas A, Zetterberg H, MacKay C, Lovestone S, Rochesteron L; Deep and Frequent Phenotyping study team (.

J Alzheimers Dis. 2018;63(1):331-341. doi: 10.3233/JAD-171116. Erratum in: J Alzheimers Dis. 2018;63(4):1557.


VLR Recognition of TLR5 Expands the Molecular Characterization of Protein Antigen Binding by Non-Ig-based Antibodies.

Gunn RJ, Herrin BR, Acharya S, Cooper MD, Wilson IA.

J Mol Biol. 2018 Apr 27;430(9):1350-1367. doi: 10.1016/j.jmb.2018.03.016. Epub 2018 Mar 26.


Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Site in Human Brain.

Tyacke RJ, Myers JFM, Venkataraman A, Mick I, Turton S, Passchier J, Husbands SM, Rabiner EA, Gunn RN, Murphy PS, Parker CA, Nutt DJ.

J Nucl Med. 2018 Oct;59(10):1597-1602. doi: 10.2967/jnumed.118.208009. Epub 2018 Mar 9.


Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451.

Firouzian A, Whittington A, Searle GE, Koychev I, Zamboni G, Lovestone S, Gunn RN; Deep and Frequent Phenotyping study team.

EJNMMI Res. 2018 Mar 2;8(1):19. doi: 10.1186/s13550-018-0371-y.


A guide to manufacturing CAR T cell therapies.

Vormittag P, Gunn R, Ghorashian S, Veraitch FS.

Curr Opin Biotechnol. 2018 Oct;53:164-181. doi: 10.1016/j.copbio.2018.01.025. Epub 2018 Feb 18. Review.


A qualitative study of patient experiences of care in integrated behavioral health and primary care settings: more similar than different.

Davis MM, Gunn R, Gowen LK, Miller BF, Green LA, Cohen DJ.

Transl Behav Med. 2018 Sep 8;8(5):649-659. doi: 10.1093/tbm/ibx001.


Translocator Protein as an Imaging Marker of Macrophage and Stromal Activation in Rheumatoid Arthritis Pannus.

Narayan N, Owen DR, Mandhair H, Smyth E, Carlucci F, Saleem A, Gunn RN, Rabiner EA, Wells L, Dakin SG, Sabokbar A, Taylor PC.

J Nucl Med. 2018 Jul;59(7):1125-1132. doi: 10.2967/jnumed.117.202200. Epub 2018 Jan 4.


The effects of working memory load and attention refocusing on delay discounting rates in alcohol use disorder with comorbid antisocial personality disorder.

Gunn RL, Gerst KR, Lake AJ, Finn PR.

Alcohol. 2018 Feb;66:9-14. doi: 10.1016/j.alcohol.2017.07.009. Epub 2017 Sep 23.


Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.

Scott G, Zetterberg H, Jolly A, Cole JH, De Simoni S, Jenkins PO, Feeney C, Owen DR, Lingford-Hughes A, Howes O, Patel MC, Goldstone AP, Gunn RN, Blennow K, Matthews PM, Sharp DJ.

Brain. 2018 Feb 1;141(2):459-471. doi: 10.1093/brain/awx339.


Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities.

Whittington A, Sharp DJ, Gunn RN; Alzheimer’s Disease Neuroimaging Initiative.

J Nucl Med. 2018 May;59(5):822-827. doi: 10.2967/jnumed.117.194720. Epub 2017 Nov 16.

Supplemental Content

Support Center